Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate-Reference-Cited by-同舟云学术

Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate

Published:2017-05-12 Issue:6 Volume:37 Page:684-691
ISSN:0277-0008
Container-title:Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
language:en
Short-container-title:Pharmacotherapy

Author:

Drost Sarah A.¹,Wentzell Jason R.¹²,Giguère Pierre¹²,McLurg Darcy L.¹,Sabloff Mitchell²³,Kanji Salmaan¹²,Nguyen Tiffany T.¹

Affiliation:

1. Pharmacy Department; The Ottawa Hospital; Ottawa Ontario Canada

2. The Ottawa Hospital Research Institute; Ottawa Ontario Canada

3. Division of Hematology, Department of Medicine; University of Ottawa; Ottawa Ontario Canada

Publisher

Wiley

Subject

Pharmacology (medical)

Reference18 articles.

1. High dose methotrexate with leucovorin rescue: rationale and spectrum of antitumor activity;Frei;Am J Med,1980

2. Evaluation of incidence and risk factors for high-dose methotrexate-induced nephrotoxicity;Wiczer;J Oncol Pharm Pract,2015

3. Concepts in use of high-dose methotrexate therapy;Treon;Clin Chem,1996

4. Methotrexate. Cancer Care Ontario Formulary 2012 https://www.cancercare.on.ca/toolbox/drugformulary/

5. LaCasce AS Therapeutic use and toxicity of high-dose methotrexate. UpToDate 2014 http://www.uptodate.com/contents/therapeutic-use-and-toxicity-of-high-dose-methotrexate

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chemotherapy-induced acute kidney injury: epidemiology, pathophysiology, and therapeutic approaches;Frontiers in Nephrology;2024-08-09

2. Development and validation of a model to predict acute kidney injury following high‐dose methotrexate in patients with lymphoma;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-11-14

3. Glucarpidase for Treating Adults with Delayed Methotrexate Elimination Due to Impaired Renal Function: An Economic Simulation Analysis;ClinicoEconomics and Outcomes Research;2023-03

4. Optimum Methotrexate Exposure in Patients With Suspected or Confirmed CNS Invasive Hematological Malignancies: A Systematic Critical Review;Therapeutic Drug Monitoring;2023-01-10

5. Risk factors for high‐dose methotrexate associated toxicities in patients with primary central nervous system lymphoma;Journal of Clinical Pharmacy and Therapeutics;2022-10-19